Heterogeneity of Risk and Benefit in Subgroups of COMPASS: Relatively Similar But Absolutely Different

J Am Coll Cardiol. 2019 Jul 2;73(25):3292-3294. doi: 10.1016/j.jacc.2019.05.007.
No abstract available

Keywords: clinical trials; drug therapy; peripheral artery disease.

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Aspirin*
  • Factor Xa Inhibitors
  • Platelet Aggregation Inhibitors
  • Rivaroxaban*

Substances

  • Factor Xa Inhibitors
  • Platelet Aggregation Inhibitors
  • Rivaroxaban
  • Aspirin